1415 CONFIRMATION THAT QUADRUPLE THERAPY WITH DACLATASVIR (NS5A INHIBITOR), ASUNAPREVIR (NS3 INHIBITOR) AND PEGINTERFERON/RIBAVIRIN RESULTS IN HIGH RATE OF SVR4 IN HCV GENOTYPE 1 NULL RESPONDERS

✍ Scribed by Lok, A.; Gardiner, D.; Hezode, C.; Lawitz, E.; Bourliere, M.; Everson, G.; Marcellin, P.; Rodriguez-Torres, M.; Pol, S.; Serfaty, L.; Eley, T.; Huang, S.-P.; Wind-Rotolo, M.; McPhee, F.; Grasela, D.; Pasquinelli, C.

• Book ID: 123210740
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 59 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61426-3